Evidence map›Paper›PMID 36862343›Full record

ArticleIntensive care medicine experimental2023

Changes in upper airways microbiota in ventilator-associated pneumonia.

Laura Alagna, Leonardo Mancabelli, Federico Magni, Liliane Chatenoud, Gabriele Bassi, Silvia Del Bianco, Roberto Fumagalli, Francesca Turroni, Davide Mangioni, Guglielmo M Migliorino and 12 more

Open access · goldAbstract read
In one paragraph

Article in Intensive care medicine experimental, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
2.1field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 11 citations in OpenAlex.

  1. Pooled it
  2. Factors associated withJournal of thoracic disease · 2026
    Article
  3. Article
  4. Article
  5. Review
  6. Article
  7. Respiratory tract colonization withInternational journal of critical illness and injury science
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors at 7 institutions in 1 country.

Laura AlagnaInfectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy. laura.alagna@policlinico.mi.it.ORCID http://orcid.org/0000-0001-7022-8463
Leonardo MancabelliDepartment of Medicine and Surgery, University of Parma, Parma, Italy.
Federico MagniNeurointensive Care Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Liliane ChatenoudIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Gabriele BassiIntensive Care, ASST GOM Niguarda, Milan, Italy.
Silvia Del BiancoNeurointensive Care Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Roberto FumagalliSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Francesca TurroniDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Davide MangioniInfectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Guglielmo M MigliorinoInfectious Diseases Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Christian MilaniDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Antonio MuscatelloInfectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Giovanni NattinoIstituto di Ricerche Farmacologiche Mario Negri IRCCS, Milan, Italy.
Edoardo PicettiDepartment of Anesthesia and Intensive Care, Parma University Hospital, Parma, Italy.
Riccardo PinciroliSchool of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
Sandra RossiDepartment of Anesthesia and Intensive Care, Parma University Hospital, Parma, Italy.
Tommaso TonettiDepartment of Anesthesia and Intensive Care, Parma University Hospital, Parma, Italy.
Alessia VargioluNeurointensive Care Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Alessandra BanderaInfectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
Marco VenturaDepartment of Chemistry, Life Sciences and Environmental Sustainability, University of Parma, Parma, Italy.
Giuseppe CiterioNeurointensive Care Unit, Fondazione IRCCS San Gerardo dei Tintori, Monza, Italy.
Andrea GoriInfectious Diseases Unit, Department of Internal Medicine, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy.
University of Parma · ITAzienda Ospedaliera San Gerardo · ITUniversity of Milan · ITFondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico · ITMario Negri Institute for Pharmacological Research · ITUniversity of Milano-Bicocca · ITAzienda Socio Sanitaria Territoriale Grande Ospedale Metropolitano Niguarda · IT

Funding

Italian Ministry of Health RF GR-2018-12365988SITA https://www.sitaonline.net/2017/11/vincitori-bando-lassegnazione-contributi-ricerca-2017
6 · The paper itself

Abstract

backgroundThe role of upper airways microbiota and its association with ventilator-associated pneumonia (VAP) development in mechanically ventilated (MV) patients is unclear. Taking advantage of data collected in a prospective study aimed to assess the composition and over-time variation of upper airway microbiota in patients MV for non-pulmonary reasons, we describe upper airway microbiota characteristics among VAP and NO-VAP patients.

methodsExploratory analysis of data collected in a prospective observational study on patients intubated for non-pulmonary conditions. Microbiota analysis (trough 16S-rRNA gene profiling) was performed on endotracheal aspirates (at intubation, T0, and after 72 h, T3) of patients with VAP (cases cohort) and a subgroup of NO-VAP patients (control cohort, matched according to total intubation time).

resultsSamples from 13 VAP patients and 22 NO-VAP matched controls were analyzed. At intubation (T0), patients with VAP revealed a significantly lower microbial complexity of the microbiota of the upper airways compared to NO-VAP controls (alpha diversity index of 84 ± 37 and 160 ± 102, in VAP and NO_VAP group, respectively, p-value < 0.012). Furthermore, an overall decrease in microbial diversity was observed in both groups at T3 as compared to T0. At T3, a loss of some genera (Prevotella 7, Fusobacterium, Neisseria, Escherichia-Shigella and Haemophilus) was found in VAP patients. In contrast, eight genera belonging to the Bacteroidetes, Firmicutes and Fusobacteria phyla was predominant in this group. However, it is unclear whether VAP caused dysbiosis or dysbiosis caused VAP.

conclusionsIn a small sample size of intubated patients, microbial diversity at intubation was less in patients with VAP compared to patients without VAP.

Indexed as

16S-rRNA microbial profilingCohort studyMechanical ventilationUpper airways microbiotaVAPVentilator-associated pneumonia

Identifiers

PMID36862343
PMCPMC9981834
OpenAlexW4322758638

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.